Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

34 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
High DOCK1 expression identifies a distinct prognostic subgroup of pediatric acute myeloid leukemia: Results of the Japanese Pediatric Leukemia/Lymphoma Study Group AML-05 trial.
Yoshitomi M, Tsujimoto SI, Ikeda J, Kawai T, Ohki K, Hara Y, Yamato G, Tanoshima R, Tomizawa D, Shimada A, Horibe K, Adachi S, Taga T, Tawa A, Hayashi Y, Ito S, Shiba N. Yoshitomi M, et al. Among authors: tsujimoto si. Pediatr Blood Cancer. 2024 Sep;71(9):e31151. doi: 10.1002/pbc.31151. Epub 2024 Jul 2. Pediatr Blood Cancer. 2024. PMID: 38953149
Salvage hematopoietic cell transplantation for children with acute myeloid leukemia relapsed after first transplantation: a Japanese national registry study.
Sakaguchi H, Taga T, Ishida H, Hama A, Okamoto Y, Sano H, Sato M, Koga Y, Koh K, Iwasaki F, Yoshida N, Cho Y, Okada K, Watanabe K, Watanabe A, Hasegawa D, Noguchi M, Hashii Y, Matsumoto K, Tabuchi K; Pediatric Acute Myeloid Leukemia Working Group of Japanese Society for Transplantation and Cellular Therapy. Sakaguchi H, et al. Bone Marrow Transplant. 2024 Nov;59(11):1621-1624. doi: 10.1038/s41409-024-02396-y. Epub 2024 Aug 22. Bone Marrow Transplant. 2024. PMID: 39174743 No abstract available.
Adverse prognostic impact of KIT exon 17 mutations despite negative flow cytometric measurable residual disease in pediatric acute myeloid leukemia with RUNX1::RUNX1T1.
Kato S, Tsujimoto SI, Matsubayashi J, Iwamoto S, Hiramatsu H, Okuno Y, Kamitori T, Ohki K, Deguchi T, Kiyokawa N, Kato M, Takita J, Tanaka S, Adachi S, Tomizawa D, Shiba N. Kato S, et al. Among authors: tsujimoto si. Haematologica. 2025 Jan 1;110(1):251-256. doi: 10.3324/haematol.2024.286243. Haematologica. 2025. PMID: 39234860 Free PMC article. No abstract available.
Assessing the efficacy of target adaptive sampling long-read sequencing through hereditary cancer patient genomes.
Nakamura W, Hirata M, Oda S, Chiba K, Okada A, Mateos RN, Sugawa M, Iida N, Ushiama M, Tanabe N, Sakamoto H, Sekine S, Hirasawa A, Kawai Y, Tokunaga K; NCBN Controls WGS Consortium; Tsujimoto SI, Shiba N, Ito S, Yoshida T, Shiraishi Y. Nakamura W, et al. Among authors: tsujimoto si. NPJ Genom Med. 2024 Feb 17;9(1):11. doi: 10.1038/s41525-024-00394-z. NPJ Genom Med. 2024. PMID: 38368425 Free PMC article.
High-dose cytarabine induction therapy and flow cytometric measurable residual disease monitoring for children with acute myeloid leukemia.
Tomizawa D, Matsubayashi J, Iwamoto S, Hiramatsu H, Hasegawa D, Moritake H, Hasegawa D, Terui K, Hama A, Tsujimoto SI, Kiyokawa N, Miyachi H, Deguchi T, Hashii Y, Iijima-Yamashita Y, Taki T, Noguchi Y, Koike K, Koh K, Yuza Y, Moriya Saito A, Horibe K, Taga T, Tanaka S, Adachi S. Tomizawa D, et al. Among authors: tsujimoto si. Leukemia. 2024 Jan;38(1):202-206. doi: 10.1038/s41375-023-02075-9. Epub 2023 Nov 6. Leukemia. 2024. PMID: 37926712 No abstract available.
Severe RAS-Associated Lymphoproliferative Disease Case with Increasing αβ Double-Negative T Cells with Atypical Features.
Kurita D, Shiba N, Ohya T, Murase A, Shimosato Y, Yoshitomi M, Hattori S, Sasaki K, Nishimura K, Tsujimoto SI, Takeuchi M, Tanoshima R, Kanegane H, Kitagawa N, Ito S. Kurita D, et al. Among authors: tsujimoto si. J Clin Immunol. 2023 Nov;43(8):1992-1996. doi: 10.1007/s10875-023-01566-9. Epub 2023 Aug 29. J Clin Immunol. 2023. PMID: 37644277
Risk-Stratified Therapy for Pediatric Acute Myeloid Leukemia.
Tomizawa D, Tsujimoto SI. Tomizawa D, et al. Among authors: tsujimoto si. Cancers (Basel). 2023 Aug 18;15(16):4171. doi: 10.3390/cancers15164171. Cancers (Basel). 2023. PMID: 37627199 Free PMC article. Review.
Optimizing transplantation procedures through identification of prognostic factors in second remission for children with acute myeloid leukemia with no prior history of transplant.
Ishida H, Tsujimoto SI, Hasegawa D, Sakaguchi H, Yamamoto S, Yanagimachi M, Koh K, Watanabe A, Hama A, Cho Y, Watanabe K, Noguchi M, Takeuchi M, Takita J, Washio K, Kato K, Koike T, Hashii Y, Tabuchi K, Hino M, Atsuta Y, Okamoto Y. Ishida H, et al. Among authors: tsujimoto si. Haematologica. 2024 Jan 1;109(1):312-317. doi: 10.3324/haematol.2023.283203. Haematologica. 2024. PMID: 37470138 Free PMC article. No abstract available.
34 results